Fluoroquinolone-induced arthralgia and myalgia in the treatment of sinusitis

American Journal of Rhinology

Volumn 19, Issue 4, 2005, Pages 395-399

  O Lee, Tsungju ^a   Stewart IV, Charles E ^a   Seery, Loren ^a   Church, Christopher A ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID;

ABDOMINAL PAIN; ACHILLES TENDON RUPTURE; ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTHRITIS; CHRONIC SINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE EXACERBATION; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FLATULENCE; FREQUENCY ANALYSIS; HUMAN; INCIDENCE; MALE; MYALGIA; NAUSEA; PHOTOSENSITIVITY; PRESCRIPTION; PRURITUS; RETROSPECTIVE STUDY; REVIEW; SEIZURE; SINUSITIS; SYMPTOMATOLOGY; VAGINITIS;

EID: 25144476429     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.1177/194589240501900413     Document Type: Review

References (17)

1. 31P magnetic resonance spectroscopy and in vitro contracture tests. Arthritis Rheum 46:774-778, 2002.
2. Khaliq Y, and Qhanel GG. Fluoroquinolone-associated tendinopathy: A critical review of the literature. Clin Infect Dis 36:1404-1410, 2003.
3. Van der Linden PD, Sturkenboom MCJM, Herings RMC, et al. Fluoroquinolones and risk of Achilles tendon disorders: Case-control study. BMJ 324:1306-1307, 2002.
4. Seeger JD, West WA, Fife D, et al. A case-control study describing the epidemiology of Achilles tendon rupture with a focus on fluoroquinolone antibiotics (Abs A-519). In Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17, 2003, Chicago, IL. Herndon, VA: ASM Press. p. 11.
5. Ribard P, and Kahn MF. Herndo, VA: ASM Press. p. 11. Rheumatological side-effects of quinolones. In Bailliere's Clinical Rheumatology: Drug Induced Rheumatic Diseases. Kahn MF (Ed). London: Bailliere Tindall, 175-191, 1991.
6. Hayem G, and Carbon C. A reappraisal of quinolone tolerability: The experience of their musculoskeletal adverse effects. Drug Saf 13:338-342, 1995.
7. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis 2004. Otolaryngol Head Neck Surg 130:S-S50, 2004.
8. Nadel DM, Lanza DC, and Kennedy DW. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 12:233-241, 1998.
9. Bhattacharyya N, and Shapiro J. Contemporary trends in microbiology and antibiotic resistance in otolaryngology. Auris Nasus Larynx 29:59-63, 2002.
10. Chan J, and Hadley J. The microbiology of chronic rhinosinusitis: Results of a community surveillance study. Ear Nose Throat J 80:143-145, 2001.
11. Hsu J, Lanza DC, and Kennedy DW. Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 12:243-248, 1998.
12. Fairbanks DNF. Pocket Guide to Antimicrobial Therapy in Otolaryngology-Head and Neck Surgery, 11th ed. Alexandria, VA: American Academy of Otolaryngology-Head and Neck Surgery, 2003. pp. 32-33.
13. Lipsky BA, and Baker CA. Fluoroquinolone toxicity profiles: A review focusing on newer agents. Clin Infect Dis 28:352-364, 1999.
14. Burkhardt JE, Walterspiel JN, and Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis 25:1196-1204, 1997.
15. Christ W, and Lehnert T. Toxicity of the quinolones. In The New Generation of Quinolones. Siporin C, Heifetz CL, and Domagala JM (Eds). New York: Marcel Dekker, 165-187, 1990.
16. Bertino J, and Fish D. The safety profile of the fluoroquinolones. Clin Ther 22:798-817, 2000.
17. Ortho-Mcneil Pharmaceutical, Inc. Levaquin (levofloxacin) tablets/injection and (levofloxacin in 5% dextrose) injection, package insert. Raritan, NJ: October 2003.